Nic G. Reitsam
Augsburg, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Distinct NK cell dynamics in SARIFA positive colorectal cancer patients indicate persistent patient-intrinsic immune signatures after tumor resection.
Journal: Scientific reports
Published: May 12, 2026
Correlation of [68Ga]Ga-RAYZ-8009 PET/CT Uptake with Immunohistochemical Glypican-3 Expression in Hepatocellular Carcinoma: A Proof-of-Target Study.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 14, 2026
Spatial omics and AI for clinically actionable cancer biomarkers.
Journal: PLoS medicine
Published: April 09, 2026
Direct tumour-adipocyte contact / Stroma AReactive Invasion Front Area (TAC/SARIFA) predicts adverse outcome in colorectal cancer: a focused evidence synthesis and meta-analysis.
Journal: Histopathology
Published: March 31, 2026
Energy Balance-Related Factors and Direct Tumor-Adipocyte Contact in Colorectal Cancer: Etiologic Insights from the Population-Based Netherlands Cohort Study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: January 16, 2026
SCRIPT: Stratified clinical risk prediction from pathology reports using large language models.
Journal: Journal of pathology informatics
Published: January 16, 2026
Energy Balance-Related Factors and Direct Tumor-Adipocyte Contact in Colorectal Cancer: Etiology Insights from the Population-Based Netherlands Cohort Study.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: January 16, 2026
WNT-Driven Immune Evasion Promotes Malignant Transformation of BRAF-Mutant Colorectal Cancer.
Journal: Gastroenterology
Published: January 16, 2026
Spatial dissection of antibody-drug conjugate/radiopharmaceutical therapy targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumors.
Journal: Neuro-oncology
Published: December 19, 2025
Spatial dissection of ADC/RPT targets defines heterogeneous expression landscapes and therapeutic implications in rhabdoid tumors.
Journal: Neuro-oncology
Published: December 19, 2025
Last Updated: 09/26/2026